People with von Hippel-Lindau disease (VHL) have an increased risk of having cancerous and noncancerous tumors that can develop throughout their bodies. Healthcare providers may call this disorder von Hippel-Lindau syndrome. VHL is a rare genetic disorder that happens if you inherit a specific genetic mutation. Treatment is surgery to remove tumors.
von Hippel-Lindau disease (VHL) is a rare genetic disorder that significantly increases the chance that you’ll have certain kinds of cancerous (malignant) tumors and noncancerous (benign) tumors and cysts. Healthcare providers may call this condition von Hippel-Lindau syndrome.
The condition happens if you inherit a specific genetic mutation (change). Research shows that by the time they’re 65 years old, 97% of people who carry this genetic mutation will develop tumors and other conditions that VHL causes. Surgery is the most common treatment for conditions that von Hippel-Landau disease may cause.
This condition causes tumors throughout your body, which means you may have several different symptoms depending on where tumors develop and the tumors’ sizes. Symptoms may include:
von Hippel-Lindau syndrome is an inherited disorder that may happen when one of your biological parents passes on an abnormal version of the VHL gene, a tumor suppressor gene that manages cell growth.
These genes make special proteins that put the brakes on cell growth that may cause cancer. When tumor suppressor genes mutate (change), it’s as if they switch from pressing on the brakes to hitting the gas pedal, suddenly putting cell growth into overdrive.
This disorder follows an autosomal dominant inheritance pattern. That means if you inherit an abnormal VHL gene from one of your biological parents, there’s a 50% chance that you’ll have von Hippel-Lindau disease. That being said, research shows up to 10% of people with VHL don’t have a family history of the disorder.
People with hEDS may have:
Currently, there are no tests to confirm whether someone has hEDS.
The diagnosis is made based on a person’s medical history and a physical examination.
Classical EDS (cEDS) is less common than hypermobile EDS and tends to affect the skin more.
People with cEDS may have:
Vascular EDS (vEDS) is a rare type of EDS and is often considered to be the most serious.
It affects the blood vessels and internal organs, which can cause them to split open and lead to life-threatening bleeding.
People with vEDS may have:
Kyphoscoliotic EDS (kEDS) is rare.
People with kEDS may have:
Some people have problems caused by hypermobility, but do not have any of the specific EDS conditions. They may be diagnosed with hypermobility spectrum disorder (HSD), which is treated in the same way as hEDS.
Healthcare providers may suspect you have VHL if you have symptoms of one of the conditions that von Hippel-Lindau disease may cause, like a hemangioblastoma or clear cell renal carcinoma. But genetic testing is the only way to confirm that you have the condition. If anyone in your family has von Hippel-Lindau disease, ask your healthcare provider if genetic testing is right for you.
Treatments vary depending on the type of tumor or cyst that VHL causes. Your healthcare provider will explain your treatment options. Common treatments are:
If you have this condition, you may have regular tests to monitor for signs of specific kinds of diseases. Finding and treating tumors early on may reduce the impact that von Hippel-Lindau syndrome may have on your life.
No, it can’t. von Hippel-Lindau disease occurs when a biological parent passes a genetic mutation onto their child. If you have a family history of VHL, genetic tests will determine whether you’re carrying the mutation.
While you can’t prevent von Hippel-Lindau disease, it’s helpful to know your risk and understand how VHL may affect you. If you know you’re at risk, healthcare providers can watch for signs of VHL-related tumors and move quickly to remove those tumors.
If you carry the VHL gene and plan to have a baby, a genetic counselor can help you understand the risks of passing the gene to your child.
Living with VHL can mean living with uncertainty. If you inherit the genetic mutation that causes von Hippel-Lindau disease, there’s a 50% chance you’ll have the condition. If you do, there’s a 97% chance you’ll have certain kinds of cancer and other serious illnesses.
But no one can predict exactly how VHL may affect your life. Here are some things you can do that may help you manage those challenges:
You should call your healthcare provider if you experience:
You’ve just learned you have a family history of von Hippel-Lindau disease. Here are some questions you may want to ask your healthcare provider:
Having this condition increases the chance you’ll have one or more of the following kinds of cancer:
Hemangioblastomas are the most common noncancerous tumor that may happen if you have von Hippel-Landau disease. A hemangioblastoma is a noncancerous tumor that grows in the blood vessels in your brain, spinal cord or retina.
These tumors don’t spread from where they started (metastasize), but they can grow large enough to affect nearby tissue and cause serious health issues. Hemangioblastomas associated with von Hippel-Landau disease are:
Having von Hippel-Landau disease may also increase your risk of developing the following noncancerous tumors and cysts:
This is a rare disorder that affects 1 in 36,000 people. Most people with VHL develop symptoms in their mid-20s.
EDS can be inherited, but it happen by chance in someone without a family history of the condition.
The 2 main ways EDS is inherited are:
A person with EDS can only pass on the same type of EDS to their children.
For example, the children of someone with hypermobile EDS cannot inherit vascular EDS.
The severity of the condition can vary within the same family.
Women have unique health issues. And some of the health issues that affect both men and women can affect women differently.
Search on the closest Doctor to your location and book based on specialty. EARN 10 POINTS more with CuraPOINT.
BOOKCurafile is the biggest Healthcare Curated Network Globally that serves citizens, service providers in one place.